594 related articles for article (PubMed ID: 22485168)
1. Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.
Johnstone D; Milward EA; Berretta R; Moscato P;
PLoS One; 2012; 7(4):e34341. PubMed ID: 22485168
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease.
Llano DA; Devanarayan V; Simon AJ;
Alzheimer Dis Assoc Disord; 2013; 27(3):233-43. PubMed ID: 23023094
[TBL] [Abstract][Full Text] [Related]
3. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.
Soares HD; Potter WZ; Pickering E; Kuhn M; Immermann FW; Shera DM; Ferm M; Dean RA; Simon AJ; Swenson F; Siuciak JA; Kaplow J; Thambisetty M; Zagouras P; Koroshetz WJ; Wan HI; Trojanowski JQ; Shaw LM;
Arch Neurol; 2012 Oct; 69(10):1310-7. PubMed ID: 22801723
[TBL] [Abstract][Full Text] [Related]
4. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.
Vasanthakumar A; Davis JW; Idler K; Waring JF; Asque E; Riley-Gillis B; Grosskurth S; Srivastava G; Kim S; Nho K; Nudelman KNH; Faber K; Sun Y; Foroud TM; Estrada K; Apostolova LG; Li QS; Saykin AJ;
Clin Epigenetics; 2020 Jun; 12(1):84. PubMed ID: 32539856
[TBL] [Abstract][Full Text] [Related]
5. Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer's Disease.
Ezzati A; Zammit AR; Harvey DJ; Habeck C; Hall CB; Lipton RB;
J Alzheimers Dis; 2019; 71(3):1027-1036. PubMed ID: 31476152
[TBL] [Abstract][Full Text] [Related]
6. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
Drake JD; Chambers AB; Ott BR; Daiello LA;
J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
[TBL] [Abstract][Full Text] [Related]
8. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
9. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M
J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084
[TBL] [Abstract][Full Text] [Related]
10. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
Hu WT; Holtzman DM; Fagan AM; Shaw LM; Perrin R; Arnold SE; Grossman M; Xiong C; Craig-Schapiro R; Clark CM; Pickering E; Kuhn M; Chen Y; Van Deerlin VM; McCluskey L; Elman L; Karlawish J; Chen-Plotkin A; Hurtig HI; Siderowf A; Swenson F; Lee VM; Morris JC; Trojanowski JQ; Soares H;
Neurology; 2012 Aug; 79(9):897-905. PubMed ID: 22855860
[TBL] [Abstract][Full Text] [Related]
11. Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
Souchet B; Michaïl A; Heuillet M; Dupuy-Gayral A; Haudebourg E; Pech C; Berthemy AA; Autelitano F; Billoir B; Domoto-Reilly K; Fowler C; Grabowski T; Jayadev S; Masters CL; Braudeau J
J Prev Alzheimers Dis; 2024; 11(3):567-581. PubMed ID: 38706273
[TBL] [Abstract][Full Text] [Related]
12. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.
Trojanowski JQ; Vandeerstichele H; Korecka M; Clark CM; Aisen PS; Petersen RC; Blennow K; Soares H; Simon A; Lewczuk P; Dean R; Siemers E; Potter WZ; Weiner MW; Jack CR; Jagust W; Toga AW; Lee VM; Shaw LM;
Alzheimers Dement; 2010 May; 6(3):230-8. PubMed ID: 20451871
[TBL] [Abstract][Full Text] [Related]
13. Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.
Johnston JM; Hu WT; Fardo DW; Greco SJ; Perry G; Montine TJ; Trojanowski JQ; Shaw LM; Ashford JW; Tezapsidis N;
Curr Alzheimer Res; 2014 Feb; 11(2):165-74. PubMed ID: 24359504
[TBL] [Abstract][Full Text] [Related]
14. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
Jemimah S; AlShehhi A;
BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
16. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI.
O'Bryant SE; Xiao G; Barber R; Huebinger R; Wilhelmsen K; Edwards M; Graff-Radford N; Doody R; Diaz-Arrastia R; ;
PLoS One; 2011; 6(12):e28092. PubMed ID: 22163278
[TBL] [Abstract][Full Text] [Related]
17. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
18. Identification of blood biomarkers for use in point of care diagnosis tool for Alzheimer's disease.
Jammeh E; Zhao P; Carroll C; Pearson S; Ifeachor E
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2415-2418. PubMed ID: 28268812
[TBL] [Abstract][Full Text] [Related]
19. Blood-based protein biomarkers for diagnosis of Alzheimer disease.
Doecke JD; Laws SM; Faux NG; Wilson W; Burnham SC; Lam CP; Mondal A; Bedo J; Bush AI; Brown B; De Ruyck K; Ellis KA; Fowler C; Gupta VB; Head R; Macaulay SL; Pertile K; Rowe CC; Rembach A; Rodrigues M; Rumble R; Szoeke C; Taddei K; Taddei T; Trounson B; Ames D; Masters CL; Martins RN; ;
Arch Neurol; 2012 Oct; 69(10):1318-25. PubMed ID: 22801742
[TBL] [Abstract][Full Text] [Related]
20. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
